Cargando…

Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke

OBJECTIVES: Atrial fibrillation (AF) is the most common arrhythmia treated in clinical practice and the association of this arrhythmia with stroke has long been recognized. The combination of associated factors to identify stroke risk is still unclear; therefore, we aimed to determine the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulin, Bilonda K., Cedric, Kabulo K., Tamomh, Abdelhakam G., Hui, Yang Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Qassim Uninversity 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852499/
https://www.ncbi.nlm.nih.gov/pubmed/31745392
_version_ 1783469851593932800
author Paulin, Bilonda K.
Cedric, Kabulo K.
Tamomh, Abdelhakam G.
Hui, Yang Dong
author_facet Paulin, Bilonda K.
Cedric, Kabulo K.
Tamomh, Abdelhakam G.
Hui, Yang Dong
author_sort Paulin, Bilonda K.
collection PubMed
description OBJECTIVES: Atrial fibrillation (AF) is the most common arrhythmia treated in clinical practice and the association of this arrhythmia with stroke has long been recognized. The combination of associated factors to identify stroke risk is still unclear; therefore, we aimed to determine the association between additional risk factors for non-valvular AF (NVAF) and the first onset stroke patients and investigate the predictive ability of additional risks factors such as cardiac biomarkers and AF status for odds of incident stroke. MATERIALS AND METHODS: We included 455 patients who suffered from NVAF divided into two distinct groups (case–control observational study). Those two groups were based on whether the patients were having a first onset stroke (stroke group) or not having a stroke (non-stroke group). We made the baseline characteristic of our sample group from the substantial evidence of risk factors, lifestyle, and type of AF; to controversial risk described in the new international guideline of AF. RESULTS: Statistically revealed that heart failure, coronary disease, cigarette smoking, type of AF, warfarin treatment, high sensitive troponin, and B-type natriuretic peptide (BNP) are associated with stroke in NVAF patients (P < 0.05). Otherwise, age, sex, hypertension, kidney disease, diabetes, thyroid disease, alcohol intake, season, aspirin, and D-dimer medication were not associated with stroke (P > 0.05). Multivariate analysis of age, smokers, coronary heart disease, heart failure, high sensitive troponin level, BNP, permanent AF, and warfarin was associated (P < 0.05). The combination of biomarkers with the clinical features can be useful (CHA2DS2-VASC/BS) for the prediction of stroke than CHA2DS2-VASC alone (P < 0.05). CONCLUSION: Impact of all associated factors and biological markers as additional risk factors may carry a synergy in this life-threatening event. In addition, may hold a clinical role to redefine and predict stroke events better than the current CHA2DS2-VASC.
format Online
Article
Text
id pubmed-6852499
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Qassim Uninversity
record_format MEDLINE/PubMed
spelling pubmed-68524992019-11-19 Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke Paulin, Bilonda K. Cedric, Kabulo K. Tamomh, Abdelhakam G. Hui, Yang Dong Int J Health Sci (Qassim) Original Article OBJECTIVES: Atrial fibrillation (AF) is the most common arrhythmia treated in clinical practice and the association of this arrhythmia with stroke has long been recognized. The combination of associated factors to identify stroke risk is still unclear; therefore, we aimed to determine the association between additional risk factors for non-valvular AF (NVAF) and the first onset stroke patients and investigate the predictive ability of additional risks factors such as cardiac biomarkers and AF status for odds of incident stroke. MATERIALS AND METHODS: We included 455 patients who suffered from NVAF divided into two distinct groups (case–control observational study). Those two groups were based on whether the patients were having a first onset stroke (stroke group) or not having a stroke (non-stroke group). We made the baseline characteristic of our sample group from the substantial evidence of risk factors, lifestyle, and type of AF; to controversial risk described in the new international guideline of AF. RESULTS: Statistically revealed that heart failure, coronary disease, cigarette smoking, type of AF, warfarin treatment, high sensitive troponin, and B-type natriuretic peptide (BNP) are associated with stroke in NVAF patients (P < 0.05). Otherwise, age, sex, hypertension, kidney disease, diabetes, thyroid disease, alcohol intake, season, aspirin, and D-dimer medication were not associated with stroke (P > 0.05). Multivariate analysis of age, smokers, coronary heart disease, heart failure, high sensitive troponin level, BNP, permanent AF, and warfarin was associated (P < 0.05). The combination of biomarkers with the clinical features can be useful (CHA2DS2-VASC/BS) for the prediction of stroke than CHA2DS2-VASC alone (P < 0.05). CONCLUSION: Impact of all associated factors and biological markers as additional risk factors may carry a synergy in this life-threatening event. In addition, may hold a clinical role to redefine and predict stroke events better than the current CHA2DS2-VASC. Qassim Uninversity 2019 /pmc/articles/PMC6852499/ /pubmed/31745392 Text en Copyright: © International Journal of Health Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Paulin, Bilonda K.
Cedric, Kabulo K.
Tamomh, Abdelhakam G.
Hui, Yang Dong
Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke
title Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke
title_full Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke
title_fullStr Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke
title_full_unstemmed Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke
title_short Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke
title_sort assessment of cardiac biomarkers (troponin, b-type natriuretic peptide, and d-dimer) in patients with non-valvular atrial fibrillation and stroke
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852499/
https://www.ncbi.nlm.nih.gov/pubmed/31745392
work_keys_str_mv AT paulinbilondak assessmentofcardiacbiomarkerstroponinbtypenatriureticpeptideandddimerinpatientswithnonvalvularatrialfibrillationandstroke
AT cedrickabulok assessmentofcardiacbiomarkerstroponinbtypenatriureticpeptideandddimerinpatientswithnonvalvularatrialfibrillationandstroke
AT tamomhabdelhakamg assessmentofcardiacbiomarkerstroponinbtypenatriureticpeptideandddimerinpatientswithnonvalvularatrialfibrillationandstroke
AT huiyangdong assessmentofcardiacbiomarkerstroponinbtypenatriureticpeptideandddimerinpatientswithnonvalvularatrialfibrillationandstroke